Macrogen, Inc.
038290.KQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$125.22B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $125.22 Billion |
|---|---|
| Enterprise Value | $178.87 Billion |
| Annual dividend | $300.00 |
| Dividend yield | 2.60% |
| Earnings per Share | $187.25 |
| Beta | 0.29 |
| Outstanding Shares | 10,841,400 |
Return
| Return on Equity | 6.62% |
|---|---|
| Return on Assets | 2.78% |
| Return on Invested Capital | 2.44% |
Valuation & Multiples
| P/E Ratio | 12.16 |
|---|---|
| PEG | -2.98 |
| Price to Sales | 0.62 |
| Price to Book Ratio | 0.73 |
| Enterprise Value to Revenue | 0.89 |
| Enterprise Value to EBIT | 36.59 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.62 |
| Debt to Equity | 0.71 |
Revenue Sources
No data
Next Earnings Call
Expected Date
November 18, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$37.10 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Macrogen, Inc.
529 employees
CEO: Jeongsun Seo Changhoon Kim
Macrogen, Inc. specializes in offering a wide array of services within genetic research and biotechnology. Their core offerings span various solutions, including whole-genome, clinical, and personalized DNA sequencing, as well as oligonu...